Clinical Trial Update: Evaluation of Major Cardiovascular Events in Participants With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo [Phase 3]

View source ↗

Summary

Phase 3 trial assessing major cardiovascular events in statin-intolerant patients treated with bempedoic acid versus placebo; completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• Bempedoic Acid (bempedoic acid)

Snippet

Sponsor: Esperion Therapeutics, Inc. | Conditions: Cardiovascular Diseases, Statin Adverse Reaction | Phase 3 | Status: COMPLETED | Results posted: 2024-01-03